Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 12/12/16 (What's New)

Summary

  • Clinical course of lung cancer in HIV-infected patients often rapidly progressive with shorter OS vs patients without HIV infection
  • More recent data suggest that for HIV-infected patients with well-controlled HIV viremia, systemic chemotherapy can affect survival[D'Jaen 2010; Lavolé 2009]
  • Patients receiving ART tend to tolerate chemotherapy better; however, potential for drug–drug interactions should be considered[Rudek 2011; Pillai 2013]

Action required

Keywords: Cancer

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.